Patents by Inventor Cristián Javier Pereda Ramos

Cristián Javier Pereda Ramos has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220152167
    Abstract: Aspects of the present disclosure generally relate to immunotherapy, cancer vaccines and the treatment of cancer diseases. By way of example, the present disclosure relates to novel combined with an immunologically effective amount of adjuvant, for treating cancer in a subject methods of generating such formulations, and methods of use thereof.
    Type: Application
    Filed: March 5, 2020
    Publication date: May 19, 2022
    Inventors: Flavio Andres SALAZAR ONFRAY, Cristian Javier PEREDA RAMOS, Mercedes Natalia LOPEZ NITSCHE, Maria Alejandra GLEISNER MUNOZ, Andres TITTARELLI, Fermin GONZALEZ, Fabian TEMPIO, Marisol BRIONES
  • Patent number: 9694059
    Abstract: The present invention relates to an ex vivo, fast and efficient process to obtain activated antigen-presenting cells that are useful for therapies against cancer and immune system-related diseases. At the same time, it is related to a cellular composition that contributes to stimulate the activated antigen-presenting cells to induce a specific immune response against tumors in patients with cancer or other pathologies involving immune responses.
    Type: Grant
    Filed: May 1, 2013
    Date of Patent: July 4, 2017
    Assignee: Universidad de Chile
    Inventors: Flavio Andres Salazar Onfray, Mercedes Natalia Lopez Nitsche, Cristian Javier Pereda Ramos, Raquel Elvira Aguilera Insunza, Alejandro Felipe Escobar Alvarez
  • Publication number: 20100303868
    Abstract: The present invention relates to an ex vivo, fast and efficient process to obtain activated antigen-presenting cells that are useful for therapies against cancer and immune system-related diseases. At the same time, it is related to a cellular composition that contributes to stimulate the activated antigen-presenting cells to induce a specific immune response against tumors in patients with cancer or other pathologies involving immune responses.
    Type: Application
    Filed: September 26, 2008
    Publication date: December 2, 2010
    Applicants: UNIVERSIDAD DE CHILE, ONCOBIOMED
    Inventors: Flavio Andrés Salazar Onfray, Mercedes Natalia López Nitsche, Cristián Javier Pereda Ramos, Raquel Elvira Aguilera Insunza, Alejandro Felipe Escobar Álvarez